Atlas Bio raises $12.5M seed
Announced 27 October 2026
◆ The Round
Atlas Bio raised $12.5M in seed funding, announced on 27 October 2026, led by Creandum, First Momentum Ventures, with participation from LEA Partners. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Atlas Bio
Swiss tech-bio firm developing a foundational AI model to run in silico clinical trials, simulating patient-level efficacy and safety signals to de-risk drug development and replace animal testing. Atlas Bio is based in Switzerland and currently at seed stage, operating in Biotech, AI Infrastructure.
◆ Investors
LeadCreandum, First Momentum Ventures
ParticipationLEA Partners
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links Atlas Bio's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Atlas Bio raise?
Atlas Bio raised $12.5M in its seed round, announced 2026-10-27.
Who invested in Atlas Bio's seed round?
The round was led by Creandum and First Momentum Ventures, with participation from LEA Partners.
What does Atlas Bio do?
Swiss tech-bio firm developing a foundational AI model to run in silico clinical trials, simulating patient-level efficacy and safety signals to de-risk drug development and replace animal testing.
Verified 27 October 2026 · Sources: public filings